High blood pressure affects more than 1.3 billion people worldwide and remains one of the leading causes of heart disease, stroke, kidney failure, and premature death. Despite its widespread impact, hypertension is often referred to as a "silent killer" because organ damage can develop for years before symptoms become apparent.

While routine blood pressure measurements help diagnose hypertension, they often fail to reveal the extent of damage already occurring throughout the body.

Now, researchers at the University of Oxford have developed an AI-driven technology called HyPrevent that could fundamentally change how clinicians evaluate the effects of hypertension.

The platform uses advanced machine-learning techniques to analyse large-scale clinical and imaging datasets from multiple organs, enabling it to detect hidden patterns of disease severity and uncover previously unrecognised subgroups of patients with hypertension.

According to Oxford University Innovation, the tool has been specifically designed to provide insights into hypertension-related end-organ damage and support more personalised disease management strategies.

The development highlights the growing role of artificial intelligence in cardiovascular medicine, where researchers are increasingly using machine learning to identify disease patterns invisible to conventional diagnostic methods.

Experts believe such technologies could help move healthcare beyond one-size-fits-all treatment approaches towards precision medicine tailored to an individual's biological risk profile.Oxford's AI Approach To Understanding Hypertension

The newly developed HyPrevent platform uses a novel computational framework that combines AI, contrastive learning, and multi-organ clinical and imaging data to map the biological consequences of hypertension. 

Source:Ndtv